RMD

Over the past six months (April 2026 - October 2026), ResMed's stock experienced several notable events. On April 30, 2026, the stock dropped over 4% after strong Q3 FY26 earnings due to the announcement of its CFO's retirement. On June 1, 2026, the acquisition of Noctrix Health led to a 4.1% stock decline. ResMed participated in the William Blair Growth Stock Conference on June 2, 2026. On July 7, 2026, the agreement to sell its MatrixCare software business for $490 million caused a 5.8% stock drop. On August 6, 2026, despite strong Q4 FY26 earnings, a weak 2027 revenue forecast resulted in shares dropping by 5.4%. ResMed participated in the Morgan Stanley Global Healthcare Conference on September 15, 2026. The share price declined from $281.38 on October 6, 2025, to $218.89 on October 2, 2026, and was $230.28 on October 9, 2026. Over the last 12 months, the stock's price decreased by 16.06%, but it increased by 3.58% in the past month.